One of the goals we had when we launched Open
Access Now was to stimulate debate about Open
Access within the scientific community and to
provide a forum for an exchange of views.
We have been delighted to receive a steady stream
of emails containing feedback and comments.
A particularly interesting contribution came from
Etienne Joly, an immunologist from Toulouse,
France, who included a proposal for a new system
of evaluating the impact of a scientific article and
the use of such evaluation to determine the amount
the author pays in publishing charges. Here, we
publish the beginning of his letter and the full text
can be found in the forum section of this website.
The views expressed are exclusively Dr Joly's, and
though the model he proposes is different from that
developed by BioMed Central, we felt it merited a
larger audience and hope that it will initiate debate.
The Open Access future is not yet clearly defined
and will benefit enormously from proposals and
suggestions from authors and readers. Now is the
time to contribute your ideas - we welcome your
comments.
Letters
A proposal for evaluating and rewarding
the impact of research articles
Dear Sir,
For the benefit of the scientific community, complete
Open Access to all primary scientific articles is clearly
the only way to go. But to ensure the quality of the
papers published, it is hard to conceive that scientific
publishing could be carried out except by paid
professionals. The only viable solution is therefore
for publishing charges to be levied on authors. This is
in fact very much the route followed by the pioneering
enterprise launched as BioMed Central. On the
whole, however, authors have been reluctant to publish
first-rate papers in such journals because of negative
perceptions and upfront charges for publication.
I believe, however, that it is possible to set up a
system whereby papers would be evaluated for publication
solely on their scientific soundness, whilst the
best papers would be recognized and their authors
rewarded for making important contributions. For
example I would envisage that the amount
charged for the publication of a manuscript would
be inversely related to the scientific impact of that
paper. The basis for this proposal is that papers would
be rated retroactively, and this rating would provide
the authors with a quotable evaluation of their
publication that could be used on their CV or grant
application.
Etienne Joly
CICT, Toulouse, France
News
Opening up intellectual property
A group of distinguished scientists,
economists and lawyers have signed
a letter to Kamil Idris, Director
General of the World Intellectual
Property Organisation (WIPO),
calling for investigation of "new open collaborative development models" without patents.
The 7 July letter notes "in recent years there has been an explosion of open and collaborative projects to create public goods" and claims that
these projects raise profound questions regarding
intellectual property policies. "They also provide evidence that one can achieve a high level of innovation in some areas of the modern economy without intellectual property protection,"
says the letter, adding "excessive, unbalanced or poorly designed intellectual property protections may be counter-productive".
The letter calls on WIPO to convene a meeting next
year to discuss new open models.
The letter is signed by over sixty individuals,
including prominent academics and lawyers.
These include Sir John Sulston, former director
of the Wellcome Trust Sanger Institute, near
Cambridge, UK, who won the 2002 Nobel
Prize for Medicine. Other signatories are Open
Access publishing advocate Peter Suber,
Professor of Philosophy at Earlham College,
USA, and Berkeley biologist Michael Eisen, a
founder of the Public Library of Science
(PLoS). Another signatory is Tim Hubbard,
Head of the Human Genome Analysis group at
the Wellcome Trust Sanger Institute. Hubbard
believes that current intellectual property practises
are responsible for high drug prices and
unequal access to life-saving medication.
An appendix to the letter lists seven examples
of open collaborative projects that have had a
major impact. These include the development
of free and open software and the world wide
web. The appendix also emphasizes the importance
of sharing information in the success of
the Human Genome Project and the SNP
Consortium. Open Access scientific publishing
gets a special mention, and reference is made to
PLoS and BioMed Central.
Francis Gurry, an assistant-director at the
WIPO, has been reported as saying "the Director General looks forward with enthusiasm to taking up the invitation to organize a conference to explore the scope and application of these models."
Open Access Now
is a newsletter informing
researchers in the life sciences
about the issues involved in Open
Access publishing.
Editor: Jonathan Weitzman, PhD
Publisher: BioMed Central
Letters
Funding bodies should make Open Access a condition of awarding grants
Dear Sir,
As a researcher who has been
funded for many years by public
sources (primarily from CDC and
NIH), it is my belief that the
benefits of publicly funded
research should be available to
the public. They should not have
to pay for it twice.
Public health research is not a
private enterprise, but a public
one by its very nature. Moreover
public health is a global enterprise
and must be freely available to
everyone, including the developing
world. None of us is safe until
we are all safe. Freedom from
requiring permission to read, copy
and use research literature is also
freedom of access.
Scientific information, at least in
public health, is not private
property, but most especially when
it is financed with public funds.
Government publications
(such as Environmental Health
Perspectives, one of the leading
journals in my field) are already
copyright-free, because they are
government documents. That has
not stopped any of us from trying
to publish there.
I am co-Editor-in-Chief of an Open
Access journal (Environmental
Health, a BioMed Central specialty
journal available at
http://www.ehjournal.net).
I started the journal with one of
my colleagues because I believe
in Open Access and was appalled
at the behavior of some of the
commercial publishers who were
slowly monopolizing the market,
a trend that in itself I saw as a
danger.
Dave Ozonoff
Boston University School of Public
Health,
Boston, MA, USA
Ross Upshur,
Sunnybrook and Women's
College Health Sciences Centre
Ross Upshur is the director of
the Primary Care Research Unit
at the Sunnybrook Campus of
the Sunnybrook and Women's College Health Sciences Centre.
He has published nine articles
in BMC journals.
What prompted you to
submit your first article?
I was excited by the promise of rapid
peer review and publication. I was
also impressed by the direct links to
PubMed.
How would you describe
your experiences of
publishing with BioMed
Central?
I find BioMed Central a superb
publisher to work with. It has,
perhaps, the most flawless electronic
submission process I have
experienced with very few glitches
and crashes. Peer review is prompt and has been, for the most part,
constructive and led to improvements
in the papers submitted. The other
chief virtue of BMC journals is their
speed of review and very little lag
time for publication. This reduces
the wait for papers to appear in the
literature. Indeed, one of our papers
was cited by another BMC paper
three days after it was posted, a timespan
inconceivable in print-based
journals.
What do you think you
gained from publishing in
an Open Access journal?
I believe an online Open Access
journal extends the range of readership
beyond the confines of libraries and
subscriptions and truly opens up
global communication of scientific
ideas.
WHAT, WHO and WHY?
A short guide to the players, stakeholders
and technical terms relevant to
Open Access publishing, "WHAT, WHO and WHY?" keeps readers
informed about the world of Open
Access.
What is SPARC?
The Scholarly Publishing and
Academic Resources Coalition, commonly
known as SPARC, describes
itself as a "catalyst for action". A nonprofit
organization, its overall mission
is to make scholarly journals affordable.
SPARC primarily operates in the
science, technology and medicine
(STM) arena. The European arm,
SPARC Europe, is directly affiliated
with SPARC but has a European remit
and focus.
SPARC currently operates three main
programs. The Alternatives Program
provides lower cost, direct competitors
to highly priced journals. The
Leading Edge Program sponsors projects
developing technological use or
innovative business models. And the
Scientific Communities Program supports
the development of portals for
distinct academic communities.
SPARC is also heavily involved in
encouraging action from librarians
and researchers. The Create Change
campaign encourages advocacy, while
Declaring Independence provides a
guide to running academic journals
that are controlled by the community,
rather than by commercial publishers.
Who is behind SPARC?
SPARC was created with the support
of the US-based Association of
Research Libraries (ARL). SPARC is
open to institutions from the US, as
well as the international academic and
research community, and currently has
about 200 members in North America,
Europe, Asia, and Australia. SPARC
members - primarily universities and
libraries - support SPARC through
annual membership fees.
The umbrella organization for SPARC
Europe is the Ligue des Bibliothèques
Européennes de Recherche (LIBER),
with additional support from organizations
including JISC, a joint committee
of UK further and higher education
funding bodies.
Why does SPARC exist?
SPARC was launched in June 1998 by
a group of libraries frustrated at high
journal prices and the rapid rises in
subscription costs. The founders
established SPARC to promote competition
in the scholarly publishing
marketplace. The idea was to use
libraries’ combined buying power to
aid the creation and growth of high quality,
low-priced peer-reviewed
journals.
SPARC publishes the monthly Open
Access Newsletter, edited by Peter
Suber, which includes news and analysis
about the Open Access movement.
SPARC also hosts the Open Access
Forum, an online discussion forum.